Pancreatic Cancer Research

ResearcherJiaxing UniversityActive in the last 2 years

Yiyu Shen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2842-4801; OpenAlex author ID A5021057777. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 5

  1. A novel tRNA-Derived Fragment, tRF-23-Z87HFK8SDZ inhibits malignant progression of pancreatic cancer through mediating IRS1. Co-author DOI 10.1016/j.abb.2025.110624↗
  2. CXCL5 Promotes the Malignant Phenotype of Pancreatic Cancer and Is Associated With Immune Infiltration. Co-author DOI 10.1177/11795549241271691↗
  3. CircZFR promotes pancreatic cancer progression through a novel circRNA-miRNA-mRNA pathway and stabilizing epithelial-mesenchymal transition protein. Last author DOI 10.1016/j.cellsig.2023.110661↗
  4. The prognostic value of intratumoral and peritumoral tumor-infiltrating FoxP3+Treg cells in of pancreatic adenocarcinoma: a meta-analysis. Co-author DOI 10.1186/s12957-021-02420-1↗
  5. CXCL5 expression in tumor tissues is associated with poor prognosis in patients with pancreatic cancer. Co-author DOI 10.3892/ol.2020.12120↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bin Yan Wu · 3 shared papers, 2020–2024 · strength 0.54
  2. Zhongcheng Zhou · 2 shared papers, 2023–2025 · strength 0.49
  3. Bin Wu · 2 shared papers, 2023–2025 · strength 0.49
  4. Liping Zheng · 1 shared paper, 2025 · strength 0.30
  5. Wei Wang · 1 shared paper, 2025 · strength 0.30
  6. Zhengxiang Zhong · 2 shared papers, 2020–2021 · strength 0.30
  7. Tao Wang · 1 shared paper, 2024 · strength 0.24
  8. Jing Wang · 1 shared paper, 2023 · strength 0.18
  9. Shaohan Wu · 1 shared paper, 2023 · strength 0.18
  10. Lingyu Hu · 1 shared paper, 2021 · strength 0.17
  11. Jing Wang · 1 shared paper, 2020 · strength 0.13
  12. Xiaoguang Wang · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.